MICHAEL D LOBERG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL D LOBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL D LOBERG. MICHAEL D LOBERG is Director in AMAG PHARMACEUTICALS INC. ($AVM) and Director in ARQULE INC ($ARQL) and Director in IGM Biosciences, Inc. ($IGMS).
Latest Insider Trading Transactions of MICHAEL D LOBERG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVM, ARQL, IGMS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Grant | A | 0.00 | 300 | 0 | 300 | 0 to 300 |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 2,140 | 1.6 K to 2.1 K (+33.33 %) |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 0 | 535 to 0 (-100.00 %) |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Grant | A | 0.00 | 535 | 0 | 535 | 0 to 535 |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 1,605 | 1.1 K to 1.6 K (+50.00 %) |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 0 | 535 to 0 (-100.00 %) |
| Jul 06 2020 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Grant | A | 0.00 | 535 | 0 | 535 | 0 to 535 |
| Jul 06 2020 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 535 | 0 to 535 |
| Jul 06 2020 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 0 | 535 to 0 (-100.00 %) |
| Jul 06 2020 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 39,803 | 0 | 39,803 | 0 to 39.8 K |
| Jul 06 2020 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 39,803 | 0 | 0 | 39.8 K to 0 (-100.00 %) |
| Jul 06 2020 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 39,803 | 0 | 39,803 | 0 to 39.8 K |
| Jul 06 2020 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 39,803 | 0 | 535 | 40.3 K to 535 (-98.67 %) |
| Apr 03 2020 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Grant | A | 0.00 | 535 | 0 | 40,338 | 39.8 K to 40.3 K (+1.34 %) |
| Feb 07 2020 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Option Exercise | A | 40.27 | 10,000 | 402,700 | 10,000 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 6.21 | 40,000 | 248,400 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 1.23 | 20,000 | 24,600 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 1.68 | 20,000 | 33,600 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 1.80 | 15,000 | 27,000 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 1.42 | 15,000 | 21,300 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 2.78 | 15,000 | 41,700 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 5.82 | 15,000 | 87,300 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 6.71 | 15,000 | 100,650 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 6.14 | 15,000 | 92,100 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | D | 2.48 | 20,000 | 49,600 | 0 | |
| Jan 16 2020 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Sell | U | 20.00 | 188,062 | 3,761,240 | 0 | 188.1 K to 0 (-100.00 %) |
| Sep 20 2019 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Option Exercise | C | 0.00 | 4,539 | 0 | 0 | |
| Sep 20 2019 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Option Exercise | C | 0.00 | 4,539 | 0 | 0 | |
| Sep 20 2019 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Buy | C | 0.00 | 4,539 | 0 | 39,803 | 35.3 K to 39.8 K (+12.87 %) |
| Sep 20 2019 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Buy | C | 0.00 | 4,539 | 0 | 39,803 | 35.3 K to 39.8 K (+12.87 %) |
| Sep 20 2019 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Buy | P | 18.57 | 5,000 | 92,867 | 35,264 | 30.3 K to 35.3 K (+16.52 %) |
| Sep 20 2019 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Buy | P | 18.57 | 5,000 | 92,867 | 35,264 | 30.3 K to 35.3 K (+16.52 %) |
| Sep 19 2019 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Option Exercise | A | 16.00 | 12,100 | 193,600 | 12,100 | |
| May 15 2019 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | A | 6.21 | 40,000 | 248,400 | 40,000 | |
| Apr 11 2019 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | M | 3.87 | 10,000 | 38,700 | 0 | |
| Apr 11 2019 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Buy | M | 3.87 | 10,000 | 38,700 | 172,514 | 162.5 K to 172.5 K (+6.15 %) |
| May 10 2018 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | A | 2.48 | 20,000 | 49,600 | 20,000 | |
| Jun 27 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.25 | 1,000 | 1,250 | 162,514 | 161.5 K to 162.5 K (+0.62 %) |
| May 24 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | A | 1.23 | 20,000 | 24,600 | 20,000 | |
| May 24 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.23 | 813 | 1,000 | 161,514 | 160.7 K to 161.5 K (+0.51 %) |
| May 22 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.22 | 2,561 | 3,124 | 160,701 | 158.1 K to 160.7 K (+1.62 %) |
| Apr 27 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.01 | 618 | 624 | 158,140 | 157.5 K to 158.1 K (+0.39 %) |
| Mar 22 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.18 | 847 | 999 | 157,522 | 156.7 K to 157.5 K (+0.54 %) |
| Mar 16 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.22 | 1,024 | 1,249 | 156,675 | 155.7 K to 156.7 K (+0.66 %) |
| Mar 02 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.30 | 480 | 624 | 155,651 | 155.2 K to 155.7 K (+0.31 %) |
| Feb 21 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.20 | 2,604 | 3,125 | 155,171 | 152.6 K to 155.2 K (+1.71 %) |
| Jan 18 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.53 | 653 | 999 | 152,567 | 151.9 K to 152.6 K (+0.43 %) |
| Jan 13 2017 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.49 | 838 | 1,249 | 151,914 | 151.1 K to 151.9 K (+0.55 %) |
| Dec 06 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.36 | 459 | 624 | 151,076 | 150.6 K to 151.1 K (+0.30 %) |
| Nov 21 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.40 | 2,232 | 3,125 | 150,617 | 148.4 K to 150.6 K (+1.50 %) |
| Nov 16 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.38 | 724 | 999 | 148,385 | 147.7 K to 148.4 K (+0.49 %) |
| Nov 09 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.28 | 976 | 1,249 | 147,661 | 146.7 K to 147.7 K (+0.67 %) |
| Oct 26 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.41 | 443 | 625 | 146,685 | 146.2 K to 146.7 K (+0.30 %) |
| Sep 22 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.60 | 1,250 | 2,000 | 146,242 | 145 K to 146.2 K (+0.86 %) |
| Sep 14 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.47 | 850 | 1,250 | 144,994 | 144.1 K to 145 K (+0.59 %) |
| Aug 22 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.53 | 2,042 | 3,124 | 144,142 | 142.1 K to 144.1 K (+1.44 %) |
| Jul 28 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.63 | 383 | 624 | 142,100 | 141.7 K to 142.1 K (+0.27 %) |
| Jul 19 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.63 | 613 | 999 | 141,717 | 141.1 K to 141.7 K (+0.43 %) |
| Jul 12 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.71 | 730 | 1,248 | 141,104 | 140.4 K to 141.1 K (+0.52 %) |
| May 25 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | A | 1.68 | 20,000 | 33,600 | 20,000 | |
| May 25 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.68 | 595 | 1,000 | 140,374 | 139.8 K to 140.4 K (+0.43 %) |
| May 19 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.59 | 1,965 | 3,124 | 139,779 | 137.8 K to 139.8 K (+1.43 %) |
| May 12 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.63 | 766 | 1,249 | 137,814 | 137 K to 137.8 K (+0.56 %) |
| Apr 27 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.67 | 374 | 625 | 137,048 | 136.7 K to 137 K (+0.27 %) |
| Mar 23 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.73 | 578 | 1,000 | 136,674 | 136.1 K to 136.7 K (+0.42 %) |
| Mar 16 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.61 | 776 | 1,249 | 136,096 | 135.3 K to 136.1 K (+0.57 %) |
| Feb 25 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.86 | 336 | 625 | 135,320 | 135 K to 135.3 K (+0.25 %) |
| Feb 22 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.85 | 1,689 | 3,125 | 134,984 | 133.3 K to 135 K (+1.27 %) |
| Jan 20 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.79 | 558 | 999 | 133,295 | 132.7 K to 133.3 K (+0.42 %) |
| Jan 07 2016 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 2.10 | 595 | 1,250 | 132,737 | 132.1 K to 132.7 K (+0.45 %) |
| Dec 18 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Buy | P | 2.16 | 3,719 | 8,030 | 132,142 | 128.4 K to 132.1 K (+2.90 %) |
| Dec 17 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Buy | P | 2.14 | 1,231 | 2,633 | 128,423 | 127.2 K to 128.4 K (+0.97 %) |
| Dec 11 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 2.12 | 294 | 623 | 127,192 | 126.9 K to 127.2 K (+0.23 %) |
| Nov 19 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 2.44 | 1,280 | 3,123 | 126,898 | 125.6 K to 126.9 K (+1.02 %) |
| Nov 18 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 2.43 | 411 | 999 | 125,618 | 125.2 K to 125.6 K (+0.33 %) |
| Nov 13 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 2.48 | 504 | 1,250 | 125,207 | 124.7 K to 125.2 K (+0.40 %) |
| Oct 29 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 2.31 | 270 | 624 | 124,703 | 124.4 K to 124.7 K (+0.22 %) |
| Sep 23 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 2.05 | 975 | 1,999 | 124,433 | 123.5 K to 124.4 K (+0.79 %) |
| Sep 16 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.74 | 718 | 1,249 | 123,458 | 122.7 K to 123.5 K (+0.58 %) |
| Aug 19 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.70 | 1,838 | 3,125 | 122,740 | 120.9 K to 122.7 K (+1.52 %) |
| Jul 30 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.70 | 367 | 624 | 120,902 | 120.5 K to 120.9 K (+0.30 %) |
| Jul 29 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.76 | 568 | 1,000 | 120,535 | 120 K to 120.5 K (+0.47 %) |
| Jul 15 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.61 | 776 | 1,249 | 119,967 | 119.2 K to 120 K (+0.65 %) |
| Jun 01 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.80 | 555 | 999 | 119,191 | 118.6 K to 119.2 K (+0.47 %) |
| May 19 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.85 | 1,689 | 3,125 | 118,636 | 116.9 K to 118.6 K (+1.44 %) |
| May 12 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Option Exercise | A | 1.80 | 15,000 | 27,000 | 15,000 | |
| May 12 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.80 | 555 | 999 | 116,947 | 116.4 K to 116.9 K (+0.48 %) |
| May 12 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.85 | 675 | 1,249 | 116,392 | 115.7 K to 116.4 K (+0.58 %) |
| May 01 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 2.05 | 304 | 623 | 115,717 | 115.4 K to 115.7 K (+0.26 %) |
| Mar 19 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 2.27 | 440 | 999 | 115,413 | 115 K to 115.4 K (+0.38 %) |
| Feb 26 2015 | ARQL | ARQULE INC | LOBERG MICHAEL D | Director | Grant | A | 1.65 | 378 | 624 | 114,973 | 114.6 K to 115 K (+0.33 %) |
| Nov 05 2003 | AVM | AMAG PHARMACEUTICA ... | LOBERG MICHAEL D | Director | Option Exercise | A | 9.40 | 8,000 | 75,200 | 63,000 |
Page: 1